- Investing Ideas
- /
- Global Large Cap High Growth Potential
Global Large Cap High Growth Potential
Results
632
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
632 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ONON | US$53.74 | 2.0% | 94.9% | US$17.1b | US$58.60 | PE120.8x | E29.7% | n/a | Consumer Durables | ||
ALNY | US$248.79 | -6.0% | 52.7% | US$30.2b | US$301.21 | PS15.3x | E70.7% | n/a | Pharmaceuticals & Biotech | ||
RHM | €596.40 | 4.1% | 106.4% | €25.9b | €664.93 | PE37.8x | E29.1% | 1.0% | Capital Goods | ||
NVDA | US$145.89 | -0.3% | 199.5% | US$3.6t | US$161.03 | PE67.4x | E23.2% | 0.03% | Semiconductors | ||
SRPT | US$110.86 | -1.4% | 32.3% | US$10.2b | US$189.86 | PE86.9x | E42.6% | n/a | Pharmaceuticals & Biotech | ||
ARES | US$171.89 | 2.7% | 58.0% | US$53.3b | US$174.38 | PE80.3x | E46.3% | 2.2% | Diversified Financials | ||
600760 | CN¥50.03 | -4.0% | 15.9% | CN¥140.0b | CN¥53.90 | PE56x | E28.9% | 0.8% | Capital Goods | ||
9992 | HK$80.25 | 12.2% | 232.3% | HK$101.7b | HK$77.02 | PE64.9x | E35.0% | 0.4% | Retail | ||
NU | US$13.32 | -14.8% | 64.4% | US$64.7b | US$15.94 | PB8.4x | E29.0% | n/a | Banks | ||
300308 | CN¥133.80 | -10.1% | 90.9% | CN¥152.6b | CN¥191.56 | PE31.9x | E32.6% | 0.2% | Tech | ||
511243 | ₹1,204.90 | -0.1% | 8.1% | ₹1.0t | ₹1,528.00 | PE26.3x | E21.9% | 0.2% | Diversified Financials | ||
SUZLON | ₹65.33 | 15.2% | 66.7% | ₹849.1b | ₹74.83 | PE92.9x | E39.4% | n/a | Capital Goods | ||
CGPOWER | ₹711.30 | 2.3% | 54.5% | ₹1.1t | ₹752.40 | PE121.9x | E23.4% | 0.2% | Capital Goods | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
FM | CA$18.51 | 3.2% | 34.5% | CA$15.2b | CA$21.53 | PS2.3x | E68.4% | n/a | Materials | ||
BX | US$185.03 | 1.9% | 73.3% | US$225.9b | US$168.90 | PE63.9x | E27.9% | 1.8% | Diversified Financials | ||
300502 | CN¥123.65 | -9.1% | 176.9% | CN¥89.6b | CN¥151.97 | PE46x | E36.7% | 0.1% | Tech | ||
A196170 | ₩347,500.00 | -21.3% | 375.4% | ₩18.7t | ₩390,000.00 | PS204x | E94.1% | n/a | Pharmaceuticals & Biotech | ||
KSPI | US$106.17 | -5.6% | 10.6% | US$20.9b | US$139.13 | PE10.3x | E23.7% | 6.5% | Diversified Financials | ||
ARGX | €553.60 | -2.8% | 23.2% | €33.4b | €577.45 | PS18.5x | E55.5% | n/a | Pharmaceuticals & Biotech | ||
SMCI | US$25.80 | 26.9% | -10.0% | US$16.6b | US$40.32 | PE12.5x | E24.3% | n/a | Tech | ||
600989 | CN¥16.55 | 7.1% | 13.4% | CN¥121.9b | CN¥21.74 | PE19.3x | E38.8% | 1.7% | Materials | ||
SOLARINDS | ₹9,973.50 | -0.4% | 47.8% | ₹903.4b | ₹11,698.00 | PE89.3x | E27.0% | 0.09% | Materials | ||
DUOL | US$331.14 | 2.4% | 51.5% | US$14.2b | US$327.23 | PE167.8x | E41.6% | n/a | Consumer Services |